Pre-order Enquiry
Request Free Sample
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14462328 | Publishing Date : 18-Jul-2019 | No. of pages : 99
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Therapy
1.4.3 Injectable Therapy
1.5 Market by Application
1.5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Home Settings
1.5.4 Ambulatory Surgical Centers (ASCs)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size
2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Growth Trends by Regions
2.2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (2014-2025)
2.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Manufacturers
3.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Area Served
3.3 Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product/Solution/Service
3.4 Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019)
4.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
5.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in United States
5.3 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
5.4 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
6 Europe
6.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
6.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Europe
6.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
6.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
7 China
7.1 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
7.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in China
7.3 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
7.4 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
8 Japan
8.1 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
8.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Japan
8.3 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
8.4 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
9.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
9.4 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
10 India
10.1 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
10.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in India
10.3 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
10.4 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019)
11.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Central & South America
11.3 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
11.4 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
12 International Players Profiles
12.1 Astellas Inc.
12.1.1 Astellas Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
12.1.4 Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
12.1.5 Astellas Inc. Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
12.2.4 Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Sanofi S.A
12.3.1 Sanofi S.A Company Details
12.3.2 Company Description and Business Overview
12.3.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
12.3.4 Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
12.3.5 Sanofi S.A Recent Development
12.4 Dendreon Corporation
12.4.1 Dendreon Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
12.4.4 Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
12.4.5 Dendreon Corporation Recent Development
12.5 Bayer AG
12.5.1 Bayer AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
12.5.4 Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
12.5.5 Bayer AG Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Market Segments
Table Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Covered
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type 2014-2025
Figure Oral Therapy Figures
Table Key Players of Oral Therapy
Figure Injectable Therapy Figures
Table Key Players of Injectable Therapy
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals & Clinics Case Studies
Figure Home Settings Case Studies
Figure Ambulatory Surgical Centers (ASCs) Case Studies
Figure Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2014-2019
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2014-2019
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Manufacturers in 2018
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product/Solution/Service
Table Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Type (2014-2019)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Application (2014-2019)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Application in 2018
Figure United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019)
Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019)
Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019)
Table Astellas Inc. Company Details
Table Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) (Million US$)
Figure Astellas Inc. Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
Table Astellas Inc. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Sanofi S.A Company Details
Table Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi S.A Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
Table Sanofi S.A Recent Development
Table Dendreon Corporation Company Details
Table Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$)
Figure Dendreon Corporation Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
Table Dendreon Corporation Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$)
Figure Bayer AG Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)
Table Bayer AG Recent Development
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Regions in 2025
Figure United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product (2019-2025)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product in 2025
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2019-2025)
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2019-2025
Astellas Inc.Johnson & Johnson
Sanofi S.A
Dendreon Corporation
Bayer AG
